Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group International (AAPG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.4B; returns 1 day +3.5%, 1 week +0.5%, 1 year -54.7%.

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) is a commercial-stage, global biopharmaceutical company focused on developing targeted therapies for cancer, chronic hepatitis B virus (HBV), and age-related diseases. The company's economic driver is its commercialized oncology portfolio alongside pipeline milestone expansions.

Groups AAPG belongs to

• Healthcare
• China Companies
• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Oncology
• Clinical Stage
• Cancer Therapeutics
• China Healthcare
• Hematologic Malignancies
• Hematology
• Precision Medicine
• Drug Discovery
• Unmet Medical Needs

AAPG financial model: income statement, cash flow and balance sheet